日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inflammatory index-based nomogram for risk stratification of erectile dysfunction: a cross-sectional study with dual-cohort validation and mendelian randomization analysis

基于炎症指数的勃起功能障碍风险分层列线图:一项采用双队列验证和孟德尔随机化分析的横断面研究

Shi, Zhaokun; Zhang, Yixin; Ma, Shanjin; Zhang, Chao; Meng, Xiangliang; Bai, Jianhui; Hu, Wei; Du, Hong; Yu, Yongcai; Wu, Yuli; Han, Donghui; Gu, Yanan; Qin, Weijun; Wang, Pang; Guo, Li; Zhang, Keying

Availability and stability of palliative care for family members of terminally ill patients in an integrated model of health and social care

在健康和社会护理一体化模式下,为绝症患者家属提供稳定可靠的姑息治疗。

Wang, Chunyan; Bi, Shaojie; Lu, Yanxia; Li, Yuli; Han, Bing; Xu, Min; Meng, Guiyue; Zhou, Qingbo

SOCE-mediated NFAT1-NOX2-NLRP1 inflammasome involves in lipopolysaccharide-induced neuronal damage and Aβ generation

SOCE 介导的 NFAT1-NOX2-NLRP1 炎症小体参与脂多糖诱导的神经元损伤和 Aβ 生成

Zhenghao Sun #, Xuewang Li #, Liu Yang, Xianan Dong, Yuli Han, Yan Li, Jing Luo, Weizu Li

Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR‑mediated autophagy

黄芪甲苷 IV 可通过促进 AMPK/mTOR 介导的自噬减轻 2 型糖尿病引起的肝损伤

Yunfeng Zhu #, Yong Su #, Jie Zhang, Yanhua Zhang, Yan Li, Yuli Han, Xianan Dong, Weizu Li, Weiping Li

Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice

人参皂苷 Rg1 通过抑制 SAMP8 小鼠的 NOX4/NLRP3 炎症小体改善衰老引起的肝纤维化

Yan Li #, Duoduo Zhang #, Lan Li #, Yuli Han, Xianan Dong, Liu Yang, Xuewang Li, Weizu Li, Weiping Li

Ginsenoside Rg1 alleviates lipopolysaccharide-induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells

人参皂苷 Rg1 通过抑制 HT22 细胞中的 NLRP1 炎症小体减轻脂多糖诱导的神经元损伤

Yaodong Zhang, Shixin Ding, Yali Chen, Zhenghao Sun, Junyan Zhang, Yuli Han, Xianan Dong, Zhirui Fang, Weizu Li

Experimental study of high-flow and low-expansion backfill material

高流动性低膨胀性回填材料的实验研究

Wang, Cheng; Wang, Chun; Xiong, Zuqiang; Wang, Yuli; Han, Yafeng